Targeting mitochondria for cancer therapy

1.4kCitations
Citations of this article
732Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mitochondria are the cells' powerhouse, but also their suicidal weapon store. Dozens of lethal signal transduction pathways converge on mitochondria to cause the permeabilization of the mitochondrial outer membrane, leading to the cytosolic release of pro-apoptotic proteins and to the impairment of the bioenergetic functions of mitochondria. The mitochondrial metabolism of cancer cells is deregulated owing to the use of glycolytic intermediates, which are normally destined for oxidative phosphorylation, in anabolic reactions. Activation of the cell death machinery in cancer cells by inhibiting tumour-specific alterations of the mitochondrial metabolism or by stimulating mitochondrial membrane permeabilization could therefore be promising therapeutic approaches. © 2010 Macmillan Publishers Limited. All rights reserved.

Cite

CITATION STYLE

APA

Fulda, S., Galluzzi, L., & Kroemer, G. (2010, June). Targeting mitochondria for cancer therapy. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd3137

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free